Home > CME Analysis

Is CME Group Inc. (CME) Undervalued?

Based on the current stock price of $276.73 and a P/E ratio of 26.81,CME Group Inc. has a PEG ratio of 3.03.

The Short Answer:

Most analysts consider a PEG ratio below 1.0 to be undervalued. With a ratio of 3.03, CME appears to be potentially overvalued relative to its growth rate of 8.84%.

Valuation Status
Overvalued

Based on a PEG ratio of 2.52 (adjusted for dividends).

01.02.0+
P/E Ratio
26.81
Growth Rate
8.84%
Stock Price
$276.73
Market Cap
99788783616

Compare CME vs Competitors

Use the calculator below to see how CME stacks up against other stocks in the same industry.

Analyze Any Stock

Get instant P/E, PEG, and PEGY ratios with real-time data

💡 Try popular stocks: AAPL, MSFT, GOOGL, TSLA, AMZN, NVDA, META

How we analyzed CME

We calculated the PEG (Price/Earnings-to-Growth) ratio by taking the Price-to-Earnings Ratio of 26.81and dividing it by the annual growth rate of 8.84%.

PEG = 26.81 (P/E) ÷ 8.84 (Growth) = 3.03

Frequently Asked Questions about CME

What is the current PEG Ratio for CME Group Inc. (CME)?+

The current PEG Ratio for CME Group Inc. is 3.03. A PEG ratio below 1.0 generally suggests the stock may be undervalued relative to its growth.

Is CME stock undervalued right now?+

Based on the PEG ratio of 3.03, CME Group Inc. appears to be potentially overvalued. Investors typically look for a PEG ratio below 1.0 to find undervalued growth stocks.

What is the PEGY Ratio for CME?+

The PEGY ratio for CME Group Inc. is 2.52. This metric accounts for dividend yield (1.81%), providing a more complete valuation picture.